The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diabetes Personal Softwares Market Research Report 2025
Synopsis
The global Diabetes Personal Softwares market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Diabetes Personal Softwares, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Personal Softwares.
Report Scope
The Diabetes Personal Softwares market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetes Personal Softwares market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Personal Softwares companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Glooko
Accu-Chek (Roche)
Tidepool
LifeScan, Inc (Platinum Equity)
Pharmaco Diabetes
Ascensia Diabetes Care Holdings AG
Diabeto Medtech India Pvt. Ltd
Abbott Diabetes Care
Acon Diabetes Care International
BIONIME
Custo med
Dexcom
Dottli
GlucoMe
MyLife
Nova
Tandem Diabetes Care
Trividia Health
Segment by Type
Cloud-based
On-premise
Segment by Application
Type I Diabetes
Type II Diabetes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetes Personal Softwares companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Diabetes Personal Softwares market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Diabetes Personal Softwares, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Personal Softwares.
Report Scope
The Diabetes Personal Softwares market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetes Personal Softwares market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Personal Softwares companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Glooko
Accu-Chek (Roche)
Tidepool
LifeScan, Inc (Platinum Equity)
Pharmaco Diabetes
Ascensia Diabetes Care Holdings AG
Diabeto Medtech India Pvt. Ltd
Abbott Diabetes Care
Acon Diabetes Care International
BIONIME
Custo med
Dexcom
Dottli
GlucoMe
MyLife
Nova
Tandem Diabetes Care
Trividia Health
Segment by Type
Cloud-based
On-premise
Segment by Application
Type I Diabetes
Type II Diabetes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetes Personal Softwares companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Personal Softwares Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cloud-based
1.2.3 On-premise
1.3 Market by Application
1.3.1 Global Diabetes Personal Softwares Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Type I Diabetes
1.3.3 Type II Diabetes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Personal Softwares Market Perspective (2019-2030)
2.2 Diabetes Personal Softwares Growth Trends by Region
2.2.1 Global Diabetes Personal Softwares Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Diabetes Personal Softwares Historic Market Size by Region (2019-2024)
2.2.3 Diabetes Personal Softwares Forecasted Market Size by Region (2025-2030)
2.3 Diabetes Personal Softwares Market Dynamics
2.3.1 Diabetes Personal Softwares Industry Trends
2.3.2 Diabetes Personal Softwares Market Drivers
2.3.3 Diabetes Personal Softwares Market Challenges
2.3.4 Diabetes Personal Softwares Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Personal Softwares Players by Revenue
3.1.1 Global Top Diabetes Personal Softwares Players by Revenue (2019-2024)
3.1.2 Global Diabetes Personal Softwares Revenue Market Share by Players (2019-2024)
3.2 Global Diabetes Personal Softwares Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diabetes Personal Softwares Revenue
3.4 Global Diabetes Personal Softwares Market Concentration Ratio
3.4.1 Global Diabetes Personal Softwares Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Personal Softwares Revenue in 2023
3.5 Diabetes Personal Softwares Key Players Head office and Area Served
3.6 Key Players Diabetes Personal Softwares Product Solution and Service
3.7 Date of Enter into Diabetes Personal Softwares Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Personal Softwares Breakdown Data by Type
4.1 Global Diabetes Personal Softwares Historic Market Size by Type (2019-2024)
4.2 Global Diabetes Personal Softwares Forecasted Market Size by Type (2025-2030)
5 Diabetes Personal Softwares Breakdown Data by Application
5.1 Global Diabetes Personal Softwares Historic Market Size by Application (2019-2024)
5.2 Global Diabetes Personal Softwares Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Diabetes Personal Softwares Market Size (2019-2030)
6.2 North America Diabetes Personal Softwares Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Diabetes Personal Softwares Market Size by Country (2019-2024)
6.4 North America Diabetes Personal Softwares Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetes Personal Softwares Market Size (2019-2030)
7.2 Europe Diabetes Personal Softwares Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Diabetes Personal Softwares Market Size by Country (2019-2024)
7.4 Europe Diabetes Personal Softwares Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Personal Softwares Market Size (2019-2030)
8.2 Asia-Pacific Diabetes Personal Softwares Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Diabetes Personal Softwares Market Size by Region (2019-2024)
8.4 Asia-Pacific Diabetes Personal Softwares Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diabetes Personal Softwares Market Size (2019-2030)
9.2 Latin America Diabetes Personal Softwares Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Diabetes Personal Softwares Market Size by Country (2019-2024)
9.4 Latin America Diabetes Personal Softwares Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Personal Softwares Market Size (2019-2030)
10.2 Middle East & Africa Diabetes Personal Softwares Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Diabetes Personal Softwares Market Size by Country (2019-2024)
10.4 Middle East & Africa Diabetes Personal Softwares Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Diabetes Personal Softwares Introduction
11.1.4 Medtronic Revenue in Diabetes Personal Softwares Business (2019-2024)
11.1.5 Medtronic Recent Development
11.2 Glooko
11.2.1 Glooko Company Detail
11.2.2 Glooko Business Overview
11.2.3 Glooko Diabetes Personal Softwares Introduction
11.2.4 Glooko Revenue in Diabetes Personal Softwares Business (2019-2024)
11.2.5 Glooko Recent Development
11.3 Accu-Chek (Roche)
11.3.1 Accu-Chek (Roche) Company Detail
11.3.2 Accu-Chek (Roche) Business Overview
11.3.3 Accu-Chek (Roche) Diabetes Personal Softwares Introduction
11.3.4 Accu-Chek (Roche) Revenue in Diabetes Personal Softwares Business (2019-2024)
11.3.5 Accu-Chek (Roche) Recent Development
11.4 Tidepool
11.4.1 Tidepool Company Detail
11.4.2 Tidepool Business Overview
11.4.3 Tidepool Diabetes Personal Softwares Introduction
11.4.4 Tidepool Revenue in Diabetes Personal Softwares Business (2019-2024)
11.4.5 Tidepool Recent Development
11.5 LifeScan, Inc (Platinum Equity)
11.5.1 LifeScan, Inc (Platinum Equity) Company Detail
11.5.2 LifeScan, Inc (Platinum Equity) Business Overview
11.5.3 LifeScan, Inc (Platinum Equity) Diabetes Personal Softwares Introduction
11.5.4 LifeScan, Inc (Platinum Equity) Revenue in Diabetes Personal Softwares Business (2019-2024)
11.5.5 LifeScan, Inc (Platinum Equity) Recent Development
11.6 Pharmaco Diabetes
11.6.1 Pharmaco Diabetes Company Detail
11.6.2 Pharmaco Diabetes Business Overview
11.6.3 Pharmaco Diabetes Diabetes Personal Softwares Introduction
11.6.4 Pharmaco Diabetes Revenue in Diabetes Personal Softwares Business (2019-2024)
11.6.5 Pharmaco Diabetes Recent Development
11.7 Ascensia Diabetes Care Holdings AG
11.7.1 Ascensia Diabetes Care Holdings AG Company Detail
11.7.2 Ascensia Diabetes Care Holdings AG Business Overview
11.7.3 Ascensia Diabetes Care Holdings AG Diabetes Personal Softwares Introduction
11.7.4 Ascensia Diabetes Care Holdings AG Revenue in Diabetes Personal Softwares Business (2019-2024)
11.7.5 Ascensia Diabetes Care Holdings AG Recent Development
11.8 Diabeto Medtech India Pvt. Ltd
11.8.1 Diabeto Medtech India Pvt. Ltd Company Detail
11.8.2 Diabeto Medtech India Pvt. Ltd Business Overview
11.8.3 Diabeto Medtech India Pvt. Ltd Diabetes Personal Softwares Introduction
11.8.4 Diabeto Medtech India Pvt. Ltd Revenue in Diabetes Personal Softwares Business (2019-2024)
11.8.5 Diabeto Medtech India Pvt. Ltd Recent Development
11.9 Abbott Diabetes Care
11.9.1 Abbott Diabetes Care Company Detail
11.9.2 Abbott Diabetes Care Business Overview
11.9.3 Abbott Diabetes Care Diabetes Personal Softwares Introduction
11.9.4 Abbott Diabetes Care Revenue in Diabetes Personal Softwares Business (2019-2024)
11.9.5 Abbott Diabetes Care Recent Development
11.10 Acon Diabetes Care International
11.10.1 Acon Diabetes Care International Company Detail
11.10.2 Acon Diabetes Care International Business Overview
11.10.3 Acon Diabetes Care International Diabetes Personal Softwares Introduction
11.10.4 Acon Diabetes Care International Revenue in Diabetes Personal Softwares Business (2019-2024)
11.10.5 Acon Diabetes Care International Recent Development
11.11 BIONIME
11.11.1 BIONIME Company Detail
11.11.2 BIONIME Business Overview
11.11.3 BIONIME Diabetes Personal Softwares Introduction
11.11.4 BIONIME Revenue in Diabetes Personal Softwares Business (2019-2024)
11.11.5 BIONIME Recent Development
11.12 Custo med
11.12.1 Custo med Company Detail
11.12.2 Custo med Business Overview
11.12.3 Custo med Diabetes Personal Softwares Introduction
11.12.4 Custo med Revenue in Diabetes Personal Softwares Business (2019-2024)
11.12.5 Custo med Recent Development
11.13 Dexcom
11.13.1 Dexcom Company Detail
11.13.2 Dexcom Business Overview
11.13.3 Dexcom Diabetes Personal Softwares Introduction
11.13.4 Dexcom Revenue in Diabetes Personal Softwares Business (2019-2024)
11.13.5 Dexcom Recent Development
11.14 Dottli
11.14.1 Dottli Company Detail
11.14.2 Dottli Business Overview
11.14.3 Dottli Diabetes Personal Softwares Introduction
11.14.4 Dottli Revenue in Diabetes Personal Softwares Business (2019-2024)
11.14.5 Dottli Recent Development
11.15 GlucoMe
11.15.1 GlucoMe Company Detail
11.15.2 GlucoMe Business Overview
11.15.3 GlucoMe Diabetes Personal Softwares Introduction
11.15.4 GlucoMe Revenue in Diabetes Personal Softwares Business (2019-2024)
11.15.5 GlucoMe Recent Development
11.16 MyLife
11.16.1 MyLife Company Detail
11.16.2 MyLife Business Overview
11.16.3 MyLife Diabetes Personal Softwares Introduction
11.16.4 MyLife Revenue in Diabetes Personal Softwares Business (2019-2024)
11.16.5 MyLife Recent Development
11.17 Nova
11.17.1 Nova Company Detail
11.17.2 Nova Business Overview
11.17.3 Nova Diabetes Personal Softwares Introduction
11.17.4 Nova Revenue in Diabetes Personal Softwares Business (2019-2024)
11.17.5 Nova Recent Development
11.18 Tandem Diabetes Care
11.18.1 Tandem Diabetes Care Company Detail
11.18.2 Tandem Diabetes Care Business Overview
11.18.3 Tandem Diabetes Care Diabetes Personal Softwares Introduction
11.18.4 Tandem Diabetes Care Revenue in Diabetes Personal Softwares Business (2019-2024)
11.18.5 Tandem Diabetes Care Recent Development
11.19 Trividia Health
11.19.1 Trividia Health Company Detail
11.19.2 Trividia Health Business Overview
11.19.3 Trividia Health Diabetes Personal Softwares Introduction
11.19.4 Trividia Health Revenue in Diabetes Personal Softwares Business (2019-2024)
11.19.5 Trividia Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Diabetes Personal Softwares Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Cloud-based
Table 3. Key Players of On-premise
Table 4. Global Diabetes Personal Softwares Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Diabetes Personal Softwares Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Diabetes Personal Softwares Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Diabetes Personal Softwares Market Share by Region (2019-2024)
Table 8. Global Diabetes Personal Softwares Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Diabetes Personal Softwares Market Share by Region (2025-2030)
Table 10. Diabetes Personal Softwares Market Trends
Table 11. Diabetes Personal Softwares Market Drivers
Table 12. Diabetes Personal Softwares Market Challenges
Table 13. Diabetes Personal Softwares Market Restraints
Table 14. Global Diabetes Personal Softwares Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Diabetes Personal Softwares Market Share by Players (2019-2024)
Table 16. Global Top Diabetes Personal Softwares Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Personal Softwares as of 2023)
Table 17. Ranking of Global Top Diabetes Personal Softwares Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Diabetes Personal Softwares Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Diabetes Personal Softwares Product Solution and Service
Table 21. Date of Enter into Diabetes Personal Softwares Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Diabetes Personal Softwares Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Diabetes Personal Softwares Revenue Market Share by Type (2019-2024)
Table 25. Global Diabetes Personal Softwares Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Diabetes Personal Softwares Revenue Market Share by Type (2025-2030)
Table 27. Global Diabetes Personal Softwares Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Diabetes Personal Softwares Revenue Market Share by Application (2019-2024)
Table 29. Global Diabetes Personal Softwares Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Diabetes Personal Softwares Revenue Market Share by Application (2025-2030)
Table 31. North America Diabetes Personal Softwares Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Diabetes Personal Softwares Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Diabetes Personal Softwares Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Diabetes Personal Softwares Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Diabetes Personal Softwares Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Diabetes Personal Softwares Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Diabetes Personal Softwares Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Diabetes Personal Softwares Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Diabetes Personal Softwares Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Diabetes Personal Softwares Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Diabetes Personal Softwares Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Diabetes Personal Softwares Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Diabetes Personal Softwares Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Diabetes Personal Softwares Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Diabetes Personal Softwares Market Size by Country (2025-2030) & (US$ Million)
Table 46. Medtronic Company Detail
Table 47. Medtronic Business Overview
Table 48. Medtronic Diabetes Personal Softwares Product
Table 49. Medtronic Revenue in Diabetes Personal Softwares Business (2019-2024) & (US$ Million)
Table 50. Medtronic Recent Development
Table 51. Glooko Company Detail
Table 52. Glooko Business Overview
Table 53. Glooko Diabetes Personal Softwares Product
Table 54. Glooko Revenue in Diabetes Personal Softwares Business (2019-2024) & (US$ Million)
Table 55. Glooko Recent Development
Table 56. Accu-Chek (Roche) Company Detail
Table 57. Accu-Chek (Roche) Business Overview
Table 58. Accu-Chek (Roche) Diabetes Personal Softwares Product
Table 59. Accu-Chek (Roche) Revenue in Diabetes Personal Softwares Business (2019-2024) & (US$ Million)
Table 60. Accu-Chek (Roche) Recent Development
Table 61. Tidepool Company Detail
Table 62. Tidepool Business Overview
Table 63. Tidepool Diabetes Personal Softwares Product
Table 64. Tidepool Revenue in Diabetes Personal Softwares Business (2019-2024) & (US$ Million)
Table 65. Tidepool Recent Development
Table 66. LifeScan, Inc (Platinum Equity) Company Detail
Table 67. LifeScan, Inc (Platinum Equity) Business Overview
Table 68. LifeScan, Inc (Platinum Equity) Diabetes Personal Softwares Product
Table 69. LifeScan, Inc (Platinum Equity) Revenue in Diabetes Personal Softwares Business (2019-2024) & (US$ Million)
Table 70. LifeScan, Inc (Platinum Equity) Recent Development
Table 71. Pharmaco Diabetes Company Detail
Table 72. Pharmaco Diabetes Business Overview
Table 73. Pharmaco Diabetes Diabetes Personal Softwares Product
Table 74. Pharmaco Diabetes Revenue in Diabetes Personal Softwares Business (2019-2024) & (US$ Million)
Table 75. Pharmaco Diabetes Recent Development
Table 76. Ascensia Diabetes Care Holdings AG Company Detail
Table 77. Ascensia Diabetes Care Holdings AG Business Overview
Table 78. Ascensia Diabetes Care Holdings AG Diabetes Personal Softwares Product
Table 79. Ascensia Diabetes Care Holdings AG Revenue in Diabetes Personal Softwares Business (2019-2024) & (US$ Million)
Table 80. Ascensia Diabetes Care Holdings AG Recent Development
Table 81. Diabeto Medtech India Pvt. Ltd Company Detail
Table 82. Diabeto Medtech India Pvt. Ltd Business Overview
Table 83. Diabeto Medtech India Pvt. Ltd Diabetes Personal Softwares Product
Table 84. Diabeto Medtech India Pvt. Ltd Revenue in Diabetes Personal Softwares Business (2019-2024) & (US$ Million)
Table 85. Diabeto Medtech India Pvt. Ltd Recent Development
Table 86. Abbott Diabetes Care Company Detail
Table 87. Abbott Diabetes Care Business Overview
Table 88. Abbott Diabetes Care Diabetes Personal Softwares Product
Table 89. Abbott Diabetes Care Revenue in Diabetes Personal Softwares Business (2019-2024) & (US$ Million)
Table 90. Abbott Diabetes Care Recent Development
Table 91. Acon Diabetes Care International Company Detail
Table 92. Acon Diabetes Care International Business Overview
Table 93. Acon Diabetes Care International Diabetes Personal Softwares Product
Table 94. Acon Diabetes Care International Revenue in Diabetes Personal Softwares Business (2019-2024) & (US$ Million)
Table 95. Acon Diabetes Care International Recent Development
Table 96. BIONIME Company Detail
Table 97. BIONIME Business Overview
Table 98. BIONIME Diabetes Personal Softwares Product
Table 99. BIONIME Revenue in Diabetes Personal Softwares Business (2019-2024) & (US$ Million)
Table 100. BIONIME Recent Development
Table 101. Custo med Company Detail
Table 102. Custo med Business Overview
Table 103. Custo med Diabetes Personal Softwares Product
Table 104. Custo med Revenue in Diabetes Personal Softwares Business (2019-2024) & (US$ Million)
Table 105. Custo med Recent Development
Table 106. Dexcom Company Detail
Table 107. Dexcom Business Overview
Table 108. Dexcom Diabetes Personal Softwares Product
Table 109. Dexcom Revenue in Diabetes Personal Softwares Business (2019-2024) & (US$ Million)
Table 110. Dexcom Recent Development
Table 111. Dottli Company Detail
Table 112. Dottli Business Overview
Table 113. Dottli Diabetes Personal Softwares Product
Table 114. Dottli Revenue in Diabetes Personal Softwares Business (2019-2024) & (US$ Million)
Table 115. Dottli Recent Development
Table 116. GlucoMe Company Detail
Table 117. GlucoMe Business Overview
Table 118. GlucoMe Diabetes Personal Softwares Product
Table 119. GlucoMe Revenue in Diabetes Personal Softwares Business (2019-2024) & (US$ Million)
Table 120. GlucoMe Recent Development
Table 121. MyLife Company Detail
Table 122. MyLife Business Overview
Table 123. MyLife Diabetes Personal Softwares Product
Table 124. MyLife Revenue in Diabetes Personal Softwares Business (2019-2024) & (US$ Million)
Table 125. MyLife Recent Development
Table 126. Nova Company Detail
Table 127. Nova Business Overview
Table 128. Nova Diabetes Personal Softwares Product
Table 129. Nova Revenue in Diabetes Personal Softwares Business (2019-2024) & (US$ Million)
Table 130. Nova Recent Development
Table 131. Tandem Diabetes Care Company Detail
Table 132. Tandem Diabetes Care Business Overview
Table 133. Tandem Diabetes Care Diabetes Personal Softwares Product
Table 134. Tandem Diabetes Care Revenue in Diabetes Personal Softwares Business (2019-2024) & (US$ Million)
Table 135. Tandem Diabetes Care Recent Development
Table 136. Trividia Health Company Detail
Table 137. Trividia Health Business Overview
Table 138. Trividia Health Diabetes Personal Softwares Product
Table 139. Trividia Health Revenue in Diabetes Personal Softwares Business (2019-2024) & (US$ Million)
Table 140. Trividia Health Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetes Personal Softwares Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Diabetes Personal Softwares Market Share by Type: 2023 VS 2030
Figure 3. Cloud-based Features
Figure 4. On-premise Features
Figure 5. Global Diabetes Personal Softwares Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Diabetes Personal Softwares Market Share by Application: 2023 VS 2030
Figure 7. Type I Diabetes Case Studies
Figure 8. Type II Diabetes Case Studies
Figure 9. Diabetes Personal Softwares Report Years Considered
Figure 10. Global Diabetes Personal Softwares Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Diabetes Personal Softwares Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Diabetes Personal Softwares Market Share by Region: 2023 VS 2030
Figure 13. Global Diabetes Personal Softwares Market Share by Players in 2023
Figure 14. Global Top Diabetes Personal Softwares Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Personal Softwares as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Diabetes Personal Softwares Revenue in 2023
Figure 16. North America Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Diabetes Personal Softwares Market Share by Country (2019-2030)
Figure 18. United States Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Diabetes Personal Softwares Market Share by Country (2019-2030)
Figure 22. Germany Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Diabetes Personal Softwares Market Share by Region (2019-2030)
Figure 30. China Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Diabetes Personal Softwares Market Share by Country (2019-2030)
Figure 38. Mexico Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Diabetes Personal Softwares Market Share by Country (2019-2030)
Figure 42. Turkey Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Diabetes Personal Softwares Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Medtronic Revenue Growth Rate in Diabetes Personal Softwares Business (2019-2024)
Figure 45. Glooko Revenue Growth Rate in Diabetes Personal Softwares Business (2019-2024)
Figure 46. Accu-Chek (Roche) Revenue Growth Rate in Diabetes Personal Softwares Business (2019-2024)
Figure 47. Tidepool Revenue Growth Rate in Diabetes Personal Softwares Business (2019-2024)
Figure 48. LifeScan, Inc (Platinum Equity) Revenue Growth Rate in Diabetes Personal Softwares Business (2019-2024)
Figure 49. Pharmaco Diabetes Revenue Growth Rate in Diabetes Personal Softwares Business (2019-2024)
Figure 50. Ascensia Diabetes Care Holdings AG Revenue Growth Rate in Diabetes Personal Softwares Business (2019-2024)
Figure 51. Diabeto Medtech India Pvt. Ltd Revenue Growth Rate in Diabetes Personal Softwares Business (2019-2024)
Figure 52. Abbott Diabetes Care Revenue Growth Rate in Diabetes Personal Softwares Business (2019-2024)
Figure 53. Acon Diabetes Care International Revenue Growth Rate in Diabetes Personal Softwares Business (2019-2024)
Figure 54. BIONIME Revenue Growth Rate in Diabetes Personal Softwares Business (2019-2024)
Figure 55. Custo med Revenue Growth Rate in Diabetes Personal Softwares Business (2019-2024)
Figure 56. Dexcom Revenue Growth Rate in Diabetes Personal Softwares Business (2019-2024)
Figure 57. Dottli Revenue Growth Rate in Diabetes Personal Softwares Business (2019-2024)
Figure 58. GlucoMe Revenue Growth Rate in Diabetes Personal Softwares Business (2019-2024)
Figure 59. MyLife Revenue Growth Rate in Diabetes Personal Softwares Business (2019-2024)
Figure 60. Nova Revenue Growth Rate in Diabetes Personal Softwares Business (2019-2024)
Figure 61. Tandem Diabetes Care Revenue Growth Rate in Diabetes Personal Softwares Business (2019-2024)
Figure 62. Trividia Health Revenue Growth Rate in Diabetes Personal Softwares Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
